NCT00918567View on ClinicalTrials.gov

Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD

PHASE4CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

September 30, 2008

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

atomoxetine

open label treatment dosed up to 1.8mg/kg/day

BEHAVIORAL

Behavior Modification Therapy

8 week behavioral modification course with school consultation, parenting groups using COPE and child social skills group

Trial Locations (1)

14214

Cennter for Children and Families, Buffalo

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

State University of New York at Buffalo

OTHER

NCT00918567 - Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD | Biotech Hunter | Biotech Hunter